On this page

CMS RVU26D · Effective 2026-10-01

64612 Facial chemodenervation Medicare reimbursement rates in Rhode Island

Report 64612 for botulinum toxin treatment of facial nerve–innervated muscles, such as in blepharospasm or hemifacial spasm, on one side. Compare 64612 office and facility rates across CMS payment localities in Rhode Island.

Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.

What does Medicare pay for 64612 in Rhode Island?

Rhode Island has 1 payment locality in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the payment area shown below, using the same CMS release.

Office / nonfacility

$144.29

1 of 1 localities have a supported rate.

Payment area: Rhode Island

One mapped payment locality.

Facility setting

$109.78

1 of 1 localities have a supported rate.

Payment area: Rhode Island

One mapped payment locality.

These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.

Find 64612 in your payment locality →

Chemodenervation

About 64612: Facial muscle chemodenervation

Report 64612 for botulinum toxin treatment of facial nerve–innervated muscles, such as in blepharospasm or hemifacial spasm, on one side.

This service uses targeted injections to reduce activity in facial muscles supplied by the facial nerve. Typical indications include blepharospasm and hemifacial spasm. Neurologists and ophthalmologists commonly perform it; other physicians with relevant expertise may provide treatment in office or facility settings. The injected muscles may include muscles around the eye or elsewhere in the face, depending on the documented disorder and treatment plan.

Select 64612 for unilateral treatment of facial nerve–innervated muscles, not by counting injection sites. For treatment on both sides, report modifier 50; CMS pays the bilateral procedure at 150%. Document the treated side, muscles, indication, and procedure performed. Related postoperative visits during the 10-day global period are included. When multiple procedures are performed in the same session, the highest-valued procedure is paid in full and the others at 50%. Assistant-at-surgery payment is statutorily restricted, and co-surgeons and team surgery are not permitted.

CMS billing rules for 64612

Global period
Minor procedure with a 10-day global period: related postoperative visits for 10 days are included.
Multiple procedures
Standard multiple procedure reduction: the highest-valued procedure is paid in full and others at 50% when performed in the same session.
Bilateral procedures
Bilateral procedure with modifier 50 is paid at 150%.
Assistant at surgery
Statutory restriction: assistant at surgery is not paid.
Co-surgeons
Co-surgeons not permitted.
Team surgery
Team surgery not permitted.

Where the value comes from

  • Work RVU1.37 · 32%
  • Practice expense (office) RVU2.58 · 61%
  • Malpractice RVU0.29 · 7%

79.5K

Medicare services in 2024 · #633 by national volume

This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.

64612 compared with similar codes

Office rates for Rhode Island, from the same CMS release.

64615

Migraine chemodenervation

Bilateral head and neck

$158.40

64612 treats facial nerve–innervated muscles, commonly for blepharospasm or hemifacial spasm. 64615 is for chronic migraine treatment involving specified head and neck muscle groups.

64616

Neck chemodenervation

Neck muscles, excluding larynx

$145.31

Use 64616 for chemodenervation of neck muscles, such as in cervical dystonia; use 64612 for facial nerve–innervated muscles.

64642

Chemodenervation

One extremity, 1–4 muscles

$166.13

64642 applies to treatment of one extremity with one to four muscles. 64612 applies to unilateral facial nerve muscle treatment.

Compare 64612 by payment locality

Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.

1 of 1 payment localities

Office and facility base rates · shared scale starting at $0

Need rates for a whole code list?

Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.

Explore fee-sheet early access →

How this local rate is calculated

Each RVU component is multiplied by its own geographic practice cost index (GPCI). The three adjusted components are added, then multiplied by the conversion factor. These are the inputs used for 64612 in Rhode Island.

PPRRVU2026_Oct_nonQPP.csv

7,169

Code
64612
Physician work
1.37
Practice expense
2.58
Malpractice
0.29

GPCI2026.csv

92

Locality
Rhode Island
Physician work
1.019
Practice expense
1.033
Malpractice
0.892
Office / nonfacility calculation for 64612 in Rhode Island
ComponentRVULocality factorAdjusted
Physician work1.37× 1.0191.3960
Practice expense2.58× 1.0332.6651
Malpractice0.29× 0.8920.2587
Total RVUs4.3198
Conversion factor× 33.4009

Office / nonfacility rate, Rhode Island$144.29

Values as parsed from CMS release RVU26D, effective 2026-10-01. The amount is rounded to the nearest cent only at the end.
Explore RVUs, geographic factors and the full formula

Office / nonfacility

Office / nonfacility calculation inputs
ComponentRVULocal GPCI
Work1.371.019
Practice expense2.581.033
Malpractice0.290.892

(1.37 × 1.019 + 2.58 × 1.033 + 0.29 × 0.892) × $33.4009 = $144.29

Facility

Facility calculation inputs
ComponentRVULocal GPCI
Work1.371.019
Practice expense1.581.033
Malpractice0.290.892

(1.37 × 1.019 + 1.58 × 1.033 + 0.29 × 0.892) × $33.4009 = $109.78

The office and facility calculations use their respective practice-expense RVUs. The facility amount here is the physician fee, not a separate hospital or facility bill.

64612 billing questions

When should 64612 be used instead of 64615?

Use 64612 for treatment of facial nerve–innervated muscles, such as for blepharospasm or hemifacial spasm. Code 64615 describes chemodenervation for chronic migraine involving specified head and neck muscle groups.

Is 64612 reported per muscle or injection site?

No. Select the code for the unilateral facial nerve muscle treatment, rather than billing a unit for each muscle or injection site.

How is treatment on both sides reported?

Report modifier 50 for bilateral treatment. CMS pays the bilateral procedure at 150%.

Are postoperative visits separately payable?

Related postoperative visits during the 10-day global period are included in the procedure payment.

Can the botulinum toxin product be reported separately?

When a separately reportable toxin product is supplied, report the applicable drug code as supported by the product and documentation. For example, J0585 describes onabotulinumtoxinA.

How does CMS apply multiple-procedure payment?

When multiple procedures are performed in the same session, CMS pays the highest-valued procedure in full and the others at 50%.

Where these rates come from

FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.

Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.

RVUs for 64612PPRRVU2026_Oct_nonQPP.csv, line 7,169 (RVU26D)
Geographic factors for Rhode IslandGPCI2026.csv, line 92 (RVU26D)